Document:

Exhibit 10.4

 

LOCK-UP AGREEMENT

 

This LOCK-UP AGREEMENT
(this “Agreement”) is made as of May 22, 2015 by and between the undersigned person or entity (the “Restricted
Holder”) and Akoustis Technologies, Inc., a Nevada corporation formerly known as Danlax, Corp. (the “Parent”).
Capitalized terms used and not otherwise defined herein shall have the meanings given to such terms in the Merger Agreement (as
defined herein).

 

WHEREAS, pursuant to
the transactions contemplated under that certain Agreement and Plan of Merger and Reorganization, dated as of May 22, 2015 (the
“Merger Agreement”), by and among the Parent, Akoustis Acquisition Corp., a Delaware corporation (the “Acquisition
Subsidiary”), and Akoustis, Inc., a Delaware corporation (the “Company”), the Acquisition Subsidiary
will merge with and into the Company, with the result of such merger being that the Company will be the surviving entity and become
a wholly-owned subsidiary of the Parent, with all the Company stockholders exchanging their shares of Company Stock for shares
of Parent Common Stock (as defined below) pursuant to the terms of the Merger Agreement (the “Merger”);

 

WHEREAS, simultaneously
with or prior to the closing of the Merger, Parent will complete a private placement offering (the “Private Placement
Offering”) of a minimum of 2,000,000 shares of common stock of the Parent, par value $0.001 per share (the “Parent
Common Stock”), at a purchase price of $1.50 per share (which includes the conversion of certain convertible notes
of the Company into Parent Common Stock);

 

WHEREAS, the Merger
Agreement provides that, among other things, all the shares of Parent Common Stock owned by the Restricted Holder and all securities
owned by the Restricted Holder that are convertible into or exercisable or exchangeable for Restricted Securities, in each case
whether owned on the date of closing of the Merger or thereafter acquired (collectively, the “Restricted Securities”)
shall be subject to certain restrictions on Disposition (as defined herein), and the Restricted Holder will be subject to certain
other restrictions relating to the Parent Common Stock, during the period of twenty-four (24) months immediately following the
closing date of the Merger (the “Restricted Period”), subject to certain conditions all as more fully set forth
herein.

 

NOW, THEREFORE, as
an inducement to and in consideration of the Parent’s agreement to enter into the Merger Agreement and proceed with the Merger,
and for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereby
agree as follows:

 

    	 

    	 

    

 

1.            Lock
Up Period.

 

(a)          During
the Restricted Period, the Restricted Holder will not, directly or indirectly: (i) offer, pledge, sell, contract to sell, sell
any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant for the sale of,
make any short sale, lend or otherwise dispose of or transfer any Restricted Securities or (ii) enter into any swap or any other
agreement or any transaction that transfers, in whole or in part, directly or indirectly, any of the economic consequences of ownership
of any Restricted Securities (with the actions described in clause (i) or (ii) above being hereinafter referred to as a “Disposition”).
The foregoing restrictions are expressly agreed to preclude the Restricted Holder from engaging in any hedging or other transaction
which is designed to or which reasonably could be expected to lead to or result in a sale or disposition of any of the Restricted
Securities of the Restricted Holder during the Restricted Period, even if such securities would be disposed of by someone other
than the Restricted Holder.

 

(b)          In
addition, during the Restricted Period, the Restricted Holder will not, directly or indirectly, effect or agree to effect any short
sale (as defined in Rule 200 under Regulation SHO of the Securities Exchange Act of 1934 (the “Exchange Act”)),
whether or not against the box, establish any “put equivalent position” (as defined in Rule 16a-1(h) under the Exchange
Act) with respect to any shares of the Parent Common Stock, borrow or pre-borrow any shares of the Parent Common Stock, or grant
any other right (including, without limitation, any put or call option) with respect to shares of the Parent Common Stock or with
respect to any security that includes, is convertible into or exercisable for or derives any significant part of its value from
shares of the Parent Common Stock or otherwise seek to hedge the Restricted Holder’s position in the Parent Common Stock.

 

(c)          Notwithstanding
anything contained herein to the contrary, the Restricted Holder shall be permitted to engage in any Disposition (i) where the
other party to such Disposition is another Restricted Holder and the transferee agrees in writing that the Restricted Securities
shall continue to be subject to the restrictions on transfer set forth in this Agreement; (ii) where such Disposition is in connection
with estate planning purposes, including, without limitation to an inter-vivos trust, and the transferee takes title to such shares
subject to the restrictions on transfer set forth in this Agreement; (iii) where such Disposition is to an affiliate of such Restricted
Holder (including entities wholly owned by such Restricted Holder or one or more trusts where such Restricted Holder is the grantor
of such trust(s)) as long as such affiliate executes a copy of this Agreement; (iv) as a distribution to stockholders, partners
or members of the Restricted Holder, provided that such stockholders, partners or members agrees in writing that the Restricted
Securities shall continue to be subject to the restrictions on transfer set forth in this Agreement; or (v) approved in advance
in writing by all of the independent directors of the Parent.

 

(d)          For
the avoidance of doubt, nothing shall prevent the Restricted Holder from, or restrict the ability of the Restricted Holder to,
exercise any options, warrants or other convertible securities issued by the Parent to the Restricted Holder or any of its affiliates,
subject to the limitations on Disposition of the shares of Parent Common Stock so acquired set forth above.

 

    	2

    	 

    

 

2.            Legends;
Stop Transfer Instructions.

 

(a)          In
addition to any legends to reflect applicable transfer restrictions under federal or state securities laws, each stock certificate
representing Restricted Securities shall be stamped or otherwise imprinted with the following legend:

 

“THE SECURITIES REPRESENTED
HEREBY ARE SUBJECT TO THE TERMS AND CONDITIONS OF A LOCK-UP AGREEMENT, DATED AS OF MAY 22, 2015, BETWEEN THE HOLDER HEREOF, AKOUSTIS
TECHNOLOGIES, INC., AND MAY ONLY BE SOLD OR TRANSFERRED IN ACCORDANCE WITH THE TERMS THEREOF.”

 

(b)          The
Restricted Holder hereby agrees and consents to the entry of stop transfer instructions with the Parent’s transfer agent
and registrar against the transfer of the Restricted Securities or securities convertible into or exchangeable for Restricted Securities
held by the Restricted Holder except in compliance with this Agreement.

 

3.            Miscellaneous.

 

(a)          Periodic
Reports. The Parent shall be permitted to request from the Restricted Holder such person’s brokerage statement summary
with respect to the Restricted Securities covering any period during the Restricted Period.

 

(b)          Specific
Performance. The Restricted Holder agrees that in the event of any breach or threatened breach by the Restricted Holder of
any covenant, obligation or other provision contained in this Agreement, then the Parent shall be entitled (in addition to any
other remedy that may be available to the Parent) to: (i) a decree or order of specific performance or mandamus to enforce the
observance and performance of such covenant, obligation or other provision; and (ii) an injunction restraining such breach or threatened
breach. The Restricted Holder further agrees that neither the Parent nor any other person or entity shall be required to obtain,
furnish or post any bond or similar instrument in connection with or as a condition to obtaining any remedy referred to in this
Section 3, and the Restricted Holder irrevocably waives any right that he, she, or it may have to require the obtaining, furnishing
or posting of any such bond or similar instrument.

 

(c)          Other
Agreements. Nothing in this Agreement shall limit any of the rights or remedies of the Parent under the Merger Agreement, or
any of the rights or remedies of the Parent or any of the obligations of the Restricted Holder under any other agreement between
the Restricted Holder and the Parent or any certificate or instrument executed by the Restricted Holder in favor of the Parent;
and nothing in the Merger Agreement or in any other agreement, certificate or instrument shall limit any of the rights or remedies
of the Parent or any of the obligations of the Restricted Holder under this Agreement.

 

(d)          Notices.
All notices, consents, waivers, and other communications which are required or permitted under this Agreement shall be in writing
will be deemed given to a party (a) on the date of delivery, if delivered to the appropriate address by hand or by nationally recognized
overnight courier service (costs prepaid); (b) the date of transmission if sent by facsimile or e-mail with confirmation of transmission
by the transmitting equipment if such notice or communication is delivered prior to 5:00 P.M., New York City time, on a business
day, or the next business day after the date of transmission, if such notice or communication is delivered on a day that is not
a business day or later than 5:00 P.M., New York City time, on any trading day; (c) the date received or rejected by the addressee,
if sent by certified mail, return receipt requested; or (d) seven days after the placement of the notice into the mails (first
class postage prepaid), to the party at the address, facsimile number, or e-mail address furnished by the such party,

 

    	3

    	 

    

 

	If to the Parent:	 	With a copy (which copy shall not constitute notice hereunder) to:
	 	 	 
	Akoustis Technologies, Inc.	 	CKR Law LLP
	f/k/a Danlax, Corp.	 	1330 Avenue of the Americas
	Transportnaya Street, 58-7	 	New York, NY 10019
	Nizhneudinsk, Russia 665106	 	Attention Barrett S. DiPaolo, Esq. 
	Attn: Ivan Krikun	 	Facsimile: 212-400-6901
		 	Telephone Number: 212-400-6900
	 	 	E-mail Address: bdipaolo@ckrlaw.com
	 	 	 
	If to the Restricted Holder:	 	 
	 	 	 
	To the address set forth on the signature 

page hereto.	 	 

 

Any party may give
any notice, request, demand, claim or other communication hereunder using any other means (including personal delivery, expedited
courier, messenger service, telecopy, telex, ordinary mail or electronic mail), but no such notice, request, demand, claim or other
communication shall be deemed to have been duly given unless and until it actually is received by the party for whom it is intended.
Any party may change the address to which notices, requests, demands, claims, and other communications hereunder are to be delivered
by giving the other Parties notice in the manner herein set forth.

 

(e)          Severability.
Any term or provision of this Agreement that is invalid or unenforceable in any situation in any jurisdiction shall not affect
the validity or enforceability of the remaining terms and provisions hereof or the validity or enforceability of the offending
term or provision in any other situation or in any other jurisdiction. If the final judgment of a court of competent jurisdiction
declares that any term or provision hereof is invalid or unenforceable, the parties hereto agree that the court making such determination
shall have the power to limit the term or provision, to delete specific words or phrases, or to replace any invalid or unenforceable
term or provision with a term or provision that is valid and enforceable and that comes closest to expressing the intention of
the invalid or unenforceable term or provision, and this Agreement shall be enforceable as so modified. In the event such court
does not exercise the power granted to it in the prior sentence, the parties hereto agree to replace such invalid or unenforceable
term or provision with a valid and enforceable term or provision that will achieve, to the extent possible, the economic, business
and other purposes of such invalid or unenforceable term.

 

    	4

    	 

    

 

(f)          Applicable
Law; Jurisdiction. THIS AGREEMENT IS MADE UNDER, AND SHALL BE CONSTRUED AND ENFORCED IN ACCORDANCE WITH, THE LAWS OF THE STATE
OF NEW YORK APPLICABLE TO AGREEMENTS MADE AND TO BE PERFORMED SOLELY THEREIN, WITHOUT GIVING EFFECT TO PRINCIPLES OF CONFLICTS
OF LAW. In any action between or among any of the parties arising out of this Agreement, (i) each of the parties irrevocably
and unconditionally consents and submits to the exclusive jurisdiction and venue of the state and federal courts having jurisdiction
over New York County, New York; (ii) if any such action is commenced in a state court, then, subject to applicable law, no
party shall object to the removal of such action to any federal court having jurisdiction over New York County, New York; (iii) each
of the parties irrevocably waives the right to trial by jury; and (iv) each of the parties irrevocably consents to service
of process by first class certified mail, return receipt requested, postage prepared, to the address at which such party is to
receive notice in accordance with this Agreement.

 

(g)          Waiver;
Termination. No failure on the part of the Parent to exercise any power, right, privilege or remedy under this Agreement, and
no delay on the part of the Parent in exercising any power, right, privilege or remedy under this Agreement, shall operate as a
waiver of such power, right, privilege or remedy; and no single or partial exercise of any such power, right, privilege or remedy
shall preclude any other or further exercise thereof or of any other power, right, privilege or remedy. The Parent shall not be
deemed to have waived any claim arising out of this Agreement, or any power, right, privilege or remedy under this Agreement, unless
the waiver of such claim, power, right, privilege or remedy is expressly set forth in a written instrument duly executed and delivered
on behalf of the Parent; and any such waiver shall not be applicable or have any effect except in the specific instance in which
it is given. If the Merger Agreement is terminated, this Agreement shall thereupon terminate.

 

(h)          Captions.
The captions contained in this Agreement are for convenience of reference only, shall not be deemed to be a part of this Agreement
and shall not be referred to in connection with the construction or interpretation of this Agreement.

 

(i)          Further
Assurances. The Restricted Holder hereby represents and warrants that the Restricted Holder has full power and authority to
enter into this Agreement and that this Agreement constitutes the legal, valid and binding obligation of the Restricted Holder,
enforceable in accordance with its terms. The Restricted Holder shall execute and/or cause to be delivered to the Parent such instruments
and other documents and shall take such other actions as the Parent may reasonably request to effectuate the intent and purposes
of this Agreement.

 

(j)          Entire
Agreement. This Agreement and the Merger Agreement collectively set forth the entire understanding of the Parent and the Restricted
Holder relating to the subject matter hereof and supersedes all other prior agreements and understandings between the Parent and
the Restricted Holder relating to the subject matter hereof.

 

(k)          Non-Exclusivity.
The rights and remedies of the Parent hereunder are not exclusive of or limited by any other rights or remedies which the Parent
may have, whether at law, in equity, by contract or otherwise, all of which shall be cumulative (and not alternative).

 

    	5

    	 

    

 

(l)          Amendments.
This Agreement may not be amended, modified, altered or supplemented other than by means of a written instrument duly executed
and delivered on behalf of the Parent and the Restricted Holder.

 

(m)          Assignment.
This Agreement and all obligations of the Restricted Holder hereunder are personal to the Restricted Holder and may not be transferred
or delegated by the Restricted Holder at any time. The Parent may freely assign any or all of its rights under this Agreement,
in whole or in part, to any successor entity without obtaining the consent or approval of the Restricted Holder.

 

(n)          Binding
Nature. Subject to Section 3(m) above, this Agreement will inure to the benefit of the Parent and its successors and assigns
and will be binding upon the Restricted Holder and the Restricted Holder’s representatives, executors, administrators, estate,
heirs, successors and permitted assigns.

 

(o)          Survival.
Each of the representations, warranties, covenants and obligations contained in this Agreement shall survive the consummation of
the Merger.

 

(p)          Counterparts.
This Agreement may be executed in separate counterparts, each of which shall be deemed an original and both of which shall constitute
one and the same instrument.

 

[signature
page follows]

 

    	6

    	 

    

 

IN WITNESS WHEREOF,
the parties hereto have executed and delivered this Agreement as of the date first set forth above.

 

	 	AKOUSTIS TECHNOLOGIES, INC.
	 	 
	 	By:	 
	 	Name:	Ivan Krikun
	 	Title:	Chief Executive Officer

 

	 	RESTRICTED HOLDER:
	 	 	 
	If an individual:	 	If an entity:
	 	 	Print Name of Entity:
	Sign: 	 	 	 	 
	Print Name: 	 	 	 
	 	 	By (sign):	 
	 	 	Print Name:
	 	 	Print Title:

 

Address:Exhibit 10.5

 

SUBSCRIPTION AGREEMENT

 

This Subscription Agreement (this “Agreement”)
has been executed by the subscriber set forth on the signature page hereof (the “Subscriber”) in connection
with the private placement offering (the “Offering”) by Danlax, Corp. (intended to be renamed Akoustis
Technologies, Inc.), a Nevada corporation (the “Company”) of a minimum of $3,000,000 (the “Minimum
Offering”)1 and a maximum of $6,000,000 (the “Maximum
Offering”) of shares (the “Shares”) of the Company’s common stock, par value $0.001
per share (“Common Stock”) issued, at a purchase price of $1.50 per Share (the “Purchase
Price”). This subscription is being submitted to you in accordance with and subject to the terms and conditions described
in this Agreement, the Confidential and Non-Binding Summary Term Sheet of the Company dated April 17, 2015, relating to the Offering
(as the same may be amended or supplemented, the “Term Sheet”), and any other Disclosure Materials (as
defined below). The minimum subscription is $90,000 (60,000 Shares). The Company may accept subscriptions for less than $90,000
in its sole discretion.

 

The Shares being subscribed for pursuant
to this Agreement have not been registered under the Securities Act of 1933, as amended (the “Securities Act”).
The Offering is being made on a reasonable best efforts basis to “accredited investors,” as defined in Regulation D
under the Securities Act.

 

The Shares are being offered and sold in
connection with a reverse triangular merger (the “Merger”) between a subsidiary of the Company and Akoustis,
Inc., a Delaware corporation (“Akoustis”), and certain other transactions, on the terms and conditions
described in the Term Sheet, pursuant to which Akoustis will become a wholly owned subsidiary of the Company, and all of the outstanding
Akoustis stock will be converted into shares of the Company’s Common Stock, and Akoustis stock options and warrants (if any)
will be converted into options and warrants to purchase the Company’s Common Stock, as further described in the Term Sheet.
Prior to the first Closing (as defined below), the Company intends to change its name to “Akoustis Technologies, Inc.”
or another name that reflects its intended new business.

 

The undersigned acknowledges receipt of
a copy of the Registration Rights Agreement, substantially in the form of Exhibit A hereto (the “Registration
Rights Agreement”).

 

Each closing of the Offering (a “Closing,”
and the date on which such Closing occurs hereinafter referred to as the “Closing Date”) shall take place
at the offices of CKR Law LLP, at 1330 Avenue of the Americas, New York, New York 10019 (or such other place as is mutually agreed
to by the Company and the Placement Agents (as defined below)).

 

The initial Closing will not occur unless:

 

		a.	funds deposited in escrow as described in Section 2(b) below, plus the outstanding principal amount
of the Akoustis Notes converted into Shares, equal at least the Minimum Offering, and corresponding documentation with respect
to such amounts has been delivered by Subscribers and the holders of Akoustis Notes as described in Section 2(a) below; and

 

 

		1	Upon the Closing of the Merger and the Minimum Offering, $645,000 outstanding principal amount
of certain convertible notes of Akoustis (the “Akoustis Notes”) will be converted into 430,000 Shares at a price per
Share equal to the Purchase Price, and the aggregate principal amount so converted will be included in the gross proceeds of the
Offering for purposes of meeting the Minimum Offering amount.

 

    	 

    	 

    

 

		b.	the Merger shall have been effected (or is simultaneously effected).

 

Thereafter, the Company may conduct one
or more additional Closings for the sale of the Shares until the termination of the Offering. Unless terminated earlier by the
Company, the Offering shall continue until May 15, 2015, which date may be extended until June 15, 2015, by the Company, without
notice to any Subscriber, past, current or prospective.

 

The Term Sheet and any supplement or amendment
thereto, and any disclosure schedule or other information document, delivered to the Subscriber prior to Subscriber’s execution
of this Agreement, and any such document delivered to the Subscriber after Subscriber’s execution of this Agreement and prior
to the Closing of the Subscriber’s subscription hereunder (including, without limitation, a draft of the Current Report on
Form 8-K to be filed with the Company with the Securities and Exchange Commission (the “SEC”) within
four business days after the closing of the merger and the initial closing of the Offering (the “Super 8-K”),
are collectively referred to as the “Disclosure Materials.”

 

		1.	Subscription. The undersigned Subscriber hereby subscribes to purchase the number of Shares
set forth on the Omnibus Signature Page attached hereto, for the aggregate Purchase Price as set forth on such Omnibus Signature
Page, subject to the terms and conditions of this Agreement and on the basis of the representations, warranties, covenants and
agreements contained herein.

 

		2.	Subscription Procedure. To complete a subscription for the Shares, the Subscriber must fully
comply with the subscription procedure provided in paragraphs a. through c. of this Section on or before the Closing Date.

 

		a.	Subscription Documents. On or before the Closing Date, the Subscriber shall review, complete
and execute the Omnibus Signature Page to this Agreement, the Investor Profile, Anti-Money Laundering Form and Investor Certification,
attached hereto following the Omnibus Signature Page (collectively, the “Subscription Documents”), and
deliver the Subscription Documents to the Company’s attorneys, CKR Law LLP (“CKR”), at the address
set forth under the caption “How to subscribe for Shares in the private offering of Danlax, Corp.” below. Executed
documents may be delivered to CKR by facsimile or electronic mail (e-mail), if the Subscriber delivers the original copies of the
documents to CKR as soon as practicable thereafter.

 

		b.	Purchase Price. Simultaneously with the delivery of the Subscription Documents to CKR as
provided herein, and in any event on or prior to the Closing Date, the Subscriber shall deliver to Delaware Trust Company, in its
capacity as escrow agent (the “Escrow Agent”), the full Purchase Price by certified or other bank check
or by wire transfer of immediately available funds, pursuant to the instructions set forth under the caption “How to subscribe
for Shares in the private offering of Danlax, Corp.” below. Such funds will be held for the Purchaser’s benefit
and will be returned promptly, without interest or offset, if this Subscription Agreement is not accepted by the Company or the
Offering is terminated pursuant to its terms by the Company prior to the Closing as defined herein.

 

		c.	Company Discretion. The Subscriber understands and agrees that the Company in its sole discretion
reserves the right to accept or reject this or any other subscription for Shares, in whole or in part, notwithstanding prior receipt
by the Subscriber of notice of acceptance of this subscription. The Company shall have no obligation hereunder until the Company
shall execute and deliver to the Subscriber an executed copy of this Agreement. If this subscription is rejected in whole, or the
offering of Shares is terminated, all funds received from the Subscriber will be returned without interest or offset, and this
Agreement shall thereafter be of no further force or effect. If this subscription is rejected in part, the funds for the rejected
portion of this subscription will be returned without interest or offset, and this Agreement will continue in full force and effect
to the extent this subscription was accepted.

 

    	2

    	 

    

 

In addition, on or before the
initial Closing Date, each holder of the Akoustis Notes shall deliver to the Company an instrument in form and substance satisfactory
to the Company evidencing such holder’s agreement to convert upon the initial Closing the outstanding principal amount of
its Akoustis Notes into Shares at a price per Share equal to the Purchase Price, without additional consideration and with no further
obligation by the Company or Akoustis with respect to the Akoustis Notes.

 

		3.	Placement Agents. Northland Securities, Inc., and Katalyst Securities LLC, each a broker-dealer
licensed with FINRA, have been engaged on a co-exclusive basis as placement agents (the “Placement Agents”)
for the Offering on a reasonable best efforts basis. The Placement Agents and their sub-agents will be paid at closing a cash commission
of 10% of funds raised from investors in the Offering (or 2% in the case of certain existing Akoustis investors) in the Offering
and will receive warrants to purchase a number of shares of Common Stock equal to 10% of the number of Shares sold in the Offering
(or 2% in the case of certain existing Akoustis investors), with a term of five (5) years and at an exercise price of $1.50 per
share (the “Placement Agent Warrants”). The Placement Agent Warrants will have “weighted average”
anti-dilution protection, subject to customary exceptions. Any sub-agent of a Placement Agent that introduces investors to the
Offering will be entitled to share in the cash fees and attributable to those investors as described above, pursuant to the terms
of an executed sub-agent agreement. The Company will pay certain expenses of the Placement Agents in connection with the Offering.

 

		4.	Representations and Warranties of the Company. The Company hereby represents and warrants
to the Subscriber, as of the Closing Date and giving effect to the Merger (unless otherwise specified), the following:

 

		a)	Organization and Qualification. The Company and each of
its subsidiaries is a corporation or other business entity duly organized and validly existing in good standing under the laws
of the jurisdiction of its formation, and has the requisite corporate power to own its properties and to carry on its business
as now being conducted. The Company and each of its subsidiaries is duly qualified as a foreign corporation to do business and
is in good standing in every jurisdiction in which the nature of the business conducted by it makes such qualification necessary,
except to the extent that the failure to be so qualified or be in good standing would not have a material adverse effect on the
assets, business, condition (financial or otherwise), results of operations or future prospects of the Company and its subsidiaries
taken as a whole (a “Material Adverse Effect”). Each subsidiary of the Company is identified on Schedule
4a attached hereto. 

 

		b)	Authorization, Enforcement, Compliance with Other Instruments.
(i) The Company has the requisite corporate power and authority to enter into and perform its obligations under this Agreement,
the Registration Rights Agreement and each of the other agreements and documents that are exhibits hereto or thereto or are contemplated
hereby or thereby or necessary or desirable to effect the transactions contemplated hereby or thereby (the “Transaction
Documents”) and to issue the Shares, in accordance with the terms hereof and thereof, (ii) the execution and delivery
by the Company of each of the Transaction Documents and the consummation by it of the transactions contemplated hereby and thereby,
including, without limitation, the issuance of the Shares, have been, or will be at the time of execution of such Transaction Document,
duly authorized by the Company’s Board of Directors, and no further consent or authorization is, or will be at the time of
execution of such Transaction Document, required by the Company, its respective Board of Directors or its stockholders, (iii) each
of the Transaction Documents will be duly executed and delivered by the Company, (iv) the Transaction Documents when executed will
constitute the valid and binding obligations of the Company enforceable against the Company in accordance with their terms, except
as such enforceability may be limited by general principles of equity or applicable bankruptcy, insolvency, reorganization, moratorium,
liquidation or similar laws relating to, or affecting generally, the enforcement of creditors’ rights and remedies. 

 

    	3

    	 

    

 

		c)	Capitalization. The authorized capital stock of the Company
consists of 300,000,000 shares of Common Stock and 10,000,000 shares of preferred stock. Immediately before giving effect to the
Merger and the initial Closing of the Offering, the Company has 3,000,000 shares of Common Stock and no preferred stock issued
and outstanding. All of the outstanding shares of Common Stock and of the stock of each of the Company’s subsidiaries have
been duly authorized, validly issued and are fully paid and nonassessable. After giving effect to the Merger: (i) no shares of
capital stock of the Company or any of its subsidiaries will be subject to preemptive rights or any other similar rights or any
liens or encumbrances suffered or permitted by the Company; (ii) except as set forth on Schedule 4c(ii)
there will be no outstanding options, warrants, scrip, rights to subscribe to, calls or commitments of any character whatsoever
relating to, or securities or rights convertible into, any shares of capital stock of the Company or any of its subsidiaries, or
contracts, commitments, understandings or arrangements by which the Company or any of its subsidiaries is or may become bound to
issue additional shares of capital stock of the Company or any of its subsidiaries, (iii) there will be no outstanding debt securities
other than indebtedness as set forth in Schedule 4c(iii), (iv) other than pursuant
to the Registration Rights Agreement or as set forth in Schedule 4c(iv), there
will be no agreements or arrangements under which the Company or any of its subsidiaries is obligated to register the sale of any
of their securities under the Securities Act, (v) there will be no outstanding registration statements, and there will be no outstanding
comment letters from the SEC or any other regulatory agency; (vi) except as provided in this Agreement or as set forth in Schedule
4c(vi), there will be no securities or instruments containing anti-dilution or similar provisions,
including the right to adjust the exercise, exchange or reset price under such securities, that will be triggered by the issuance
of the Shares as described in this Agreement; and (vii) no co-sale right, right of first refusal or other similar right will exist
with respect to the Shares or the issuance and sale thereof. Immediately after giving effect to the Merger and the Closing of the
Minimum Offering or the Maximum Offering, the pro forma outstanding capitalization of the Company will be as set forth under “Pro
Forma Capitalization” in Schedule 4c. Upon request, the Company will
make available to the Subscriber true and correct copies of the Company’s Certificate of Incorporation, and as in effect
on the date hereof (the “Certificate of Incorporation”), and the Company’s By-laws, as in effect
on the date hereof (the “By-laws”), and the terms of all securities exercisable for Common Stock and
the material rights of the holders thereof in respect thereto other than stock options issued to officers, directors, employees
and consultants.

 

		d)	Issuance of Securities. The Shares are duly authorized
and, upon issuance in accordance with the terms hereof, shall be duly issued, fully paid and nonassessable, and are free from all
taxes, liens and charges with respect to the issue thereof. 

 

    	4

    	 

    

 

		e)	No Conflicts. The execution, delivery and performance
of each of the Transaction Documents by the Company, and the consummation by the Company of the transactions contemplated hereby
and thereby will not (i) result in a violation of the Certificate of Incorporation or the By-laws (or equivalent constitutive document)
of the Company or any of its subsidiaries or (ii) violate or conflict with, or result in a breach of any provision of, or constitute
a default (or an event which with notice or lapse of time or both would become a default) under, or give to others any rights of
termination, amendment, acceleration or cancellation of, any agreement, indenture or instrument to which the Company or any subsidiary
is a party, except for those which could not reasonably be expected to have a Material Adverse Effect, or (iii) result in a violation
of any law, rule, regulation, order, judgment or decree (including U.S. federal and state securities laws and regulations) applicable
to the Company or any subsidiary or by which any property or asset of the Company or any subsidiary is bound or affected. Neither
the Company nor any subsidiary is in violation of any term of or in default under its constitutive documents. Except those which
could not reasonably be expected to have a Material Adverse Effect, neither the Company nor any subsidiary is in violation of any
term of or in default under any material contract, agreement, mortgage, indebtedness, indenture, instrument, judgment, decree or
order or any statute, rule or regulation applicable to the Company or any subsidiary. The business of the Company and its subsidiaries
is not being conducted, and shall not be conducted in violation of any law, ordinance, or regulation of any governmental entity,
except for any violation which could not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect.
Except as specifically contemplated by this Agreement and as required under the Securities Act and any applicable state securities
laws, neither the Company nor any of its subsidiaries is required to obtain any consent, authorization or order of, or make any
filing or registration with, any court or governmental agency in order for it to execute, deliver or perform any of its obligations
under or contemplated by this Agreement or the other Transaction Documents in accordance with the terms hereof or thereof. Except
as set forth on Schedule 4e, neither the execution and delivery by the Company
of the Transaction Documents, nor the consummation by the Company of the transactions contemplated hereby or thereby, will require
any notice, consent or waiver under any contract or instrument to which the Company or any subsidiary is a party or by which the
Company or any subsidiary is bound or to which any of their assets is subject. All consents, authorizations, orders, filings and
registrations which the Company or any of its subsidiaries is required to obtain pursuant to the preceding two sentences have been
or will be obtained or effected on or prior to the Closing. The Company is unaware of any facts or circumstance, which might give
rise to any of the foregoing.

 

		f)	Absence of Litigation. Except as set forth on Schedule
4f, there is no action, suit, proceeding, inquiry
or investigation before or by any court, public board, government agency, self-regulatory organization or body now pending or,
to the knowledge of the Company, threatened, against or affecting the Company or any of its subsidiaries.

 

		g)	Acknowledgment Regarding Subscriber’s Purchase of the
Shares. The Company acknowledges and agrees that each Subscriber is acting solely in the capacity of an arm’s length
purchaser with respect to the Transaction Documents and the transactions contemplated hereby and thereby. 

 

		h)	No General Solicitation. Neither the Company, nor any
of its affiliates, nor, to the knowledge of the Company, any person acting on its or their behalf, has engaged in any form of general
solicitation or general advertising (within the meaning of Regulation D) in connection with the offer or sale of the Shares.

 

    	5

    	 

    

 

		i)	No Integrated Offering. Neither the Company, nor any of
its affiliates, nor to the knowledge of the Company, any person acting on its or their behalf has, directly or indirectly, made
any offers or sales of any security or solicited any offers to buy any security, under circumstances that would require registration
of the Shares under the Securities Act or cause this offering of the Shares to be integrated with prior offerings by the Company
for purposes of the Securities Act.

 

		j)	Employee Relations. Neither Company nor any subsidiary
is involved in any labor dispute nor, to the knowledge of the Company, is any such dispute threatened. Neither Company nor any
subsidiary is party to any collective bargaining agreement. The Company’s and/or its subsidiaries’ employees are not
members of any union, and the Company believes that its and its subsidiaries’ relationship with their respective employees
is good.

 

		k)	Intellectual Property Rights. Except as set forth on Schedule
4k, the Company and its subsidiaries own or possess all patents, trademarks, domain names
(whether or not registered) and any patentable improvements or copyrightable derivative works thereof, websites and intellectual
property rights relating thereto, service marks, trade names, copyrights, licenses and authorizations, and all rights with respect
to the foregoing, which are necessary for the conduct of its business as now conducted without any conflict with the rights of
others except for such conflicts that would not result in a Material Adverse Effect. Neither Company nor any subsidiary has received
any notice of infringement of, or conflict with, the asserted rights of others with respect to any intellectual property that it
utilizes.

 

		l)	Environmental Laws.

 

		(i)	The Company and each subsidiary has complied with all applicable Environmental Laws (as defined
below), except for violations of Environmental Laws that, individually or in the aggregate, have not had and would not reasonably
be expected to have a Material Adverse Effect. There is no pending or, to the knowledge of the Company, threatened civil or criminal
litigation, written notice of violation, formal administrative proceeding, or investigation, inquiry or information request, relating
to any Environmental Law involving the Company or any subsidiary, except for litigation, notices of violations, formal administrative
proceedings or investigations, inquiries or information requests that, individually or in the aggregate, have not had and would
not reasonably be expected to have a Material Adverse Effect. For purposes of this Agreement, “Environmental Law” means
any national, state, provincial or local law, statute, rule or regulation or the common law relating to the environment or occupational
health and safety, including without limitation any statute, regulation, administrative decision or order pertaining to (i) treatment,
storage, disposal, generation and transportation of industrial, toxic or hazardous materials or substances or solid or hazardous
waste; (ii) air, water and noise pollution; (iii) groundwater and soil contamination; (iv) the release or threatened release into
the environment of industrial, toxic or hazardous materials or substances, or solid or hazardous waste, including without limitation
emissions, discharges, injections, spills, escapes or dumping of pollutants, contaminants or chemicals; (v) the protection of wild
life, marine life and wetlands, including without limitation all endangered and threatened species; (vi) storage tanks, vessels,
containers, abandoned or discarded barrels, and other closed receptacles; (vii) health and safety of employees and other persons;
and (viii) manufacturing, processing, using, distributing, treating, storing, disposing, transporting or handling of materials
regulated under any law as pollutants, contaminants, toxic or hazardous materials or substances or oil or petroleum products or
solid or hazardous waste. As used above, the terms “release” and “environment” shall have the meaning set
forth in the Comprehensive Environmental Response, Compensation and Liability Act of 1980, as amended.

 

    	6

    	 

    

 

		(ii)	To the knowledge of the Company there is no material environmental liability with respect to any
solid or hazardous waste transporter or treatment, storage or disposal facility that has been used by the Company or any subsidiary.

 

		(iii)	The Company and its subsidiaries (i) have received all permits, licenses or other approvals required
of them under applicable Environmental Laws to conduct their respective businesses and (ii) are in compliance, in all material
respects, with all terms and conditions of any such permit, license or approval.

 

		m)	Permits; FCC Compliance. The Company and its subsidiaries
have all authorizations, approvals, clearances, licenses, permits, certificates or exemptions (including manufacturing approvals
and authorizations, pricing and reimbursement approvals, labeling approvals, registration notifications or their foreign equivalent)
issued by any regulatory authority or governmental agency (collectively, “Permits”) required to conduct
their respective businesses as currently conducted except to the extent that the failure to have such Permits would not have a
Material Adverse Effect. The conduct of business by the Company complies, and at all times has substantially complied, in all material
respects with the Telecommunications Act of 1996 and similar federal, state and foreign laws applicable to the evaluation, testing,
manufacturing, distribution, advertising and marketing of each of the Company’s products, in whatever stage of development
or commercialization except to the extent that the failure to so comply would not have a Material Adverse Effect. To the knowledge
of the Company, as of the date hereof, neither the Federal Communications Commission (the “FCC”) nor any comparable
regulatory authority or governmental agency is considering limiting, suspending or revoking any such Permit or changing the marketing
classification or labeling of the products of the Company or any of its subsidiaries. To the knowledge of the Company, there is
no false or misleading information or material omission in any product application or other submission by the Company or any of
its subsidiaries to the FCC or any comparable regulatory authority or governmental agency. The Company or its subsidiaries have
fulfilled and performed in all material respects their obligations under each Permit, and, as of the date hereof, to the knowledge
of the Company, no event has occurred or condition or state of facts exists which would constitute a breach or default or would
cause revocation or termination of any such Permit except to the extent that such breach, default, revocation or termination would
not have a Material Adverse Effect. To the knowledge of the Company, any third party that is a manufacturer or contractor for the
Company or any of its subsidiaries is in compliance in all material respects with all Permits insofar as they pertain to the manufacture
of product components or products for the Company. The Company and its subsidiaries have not received any notice of adverse finding,
warning letter, notice of violation, notice of action or any other notice from the FCC or other governmental agency alleging or
asserting noncompliance with any applicable laws or Permits. The Company and its subsidiaries have made all notifications, submissions
and reports required by applicable federal, state and foreign laws, except to the extent that the failure to make such notifications,
submission or reports would not have a Material Adverse Effect.

 

		n)	Title. Neither the Company nor any of its subsidiaries
owns any real property. Except as set forth on Schedule 4n, each of the Company
and its subsidiaries has good and marketable title to all of its personal property and assets, free and clear of any material restriction,
mortgage, deed of trust, pledge, lien, security interest or other charge, claim or encumbrance which would have a Material Adverse
Effect. Except as set forth on Schedule 4n, with respect to properties and assets
it leases, each of the Company and its subsidiaries is in material compliance with such leases and holds a valid leasehold interest
free of any liens, claims or encumbrances which would have a Material Adverse Effect. 

 

    	7

    	 

    

 

		o)	No Material Adverse Breaches, etc. Neither Company nor
any subsidiary is subject to any charter, corporate or other legal restriction, or any judgment, decree, order, rule or regulation
which in the judgment of the Company’s officers has had, or is reasonably expected in the future to have, a Material Adverse
Effect. Neither Company nor any subsidiary is in breach of any contract or agreement which breach, in the judgment of the Company’s
officers, has had, or is reasonably expected to have a Material Adverse Effect.

 

		p)	Tax Status. The Company and each subsidiary has made and
filed (taking into account any valid extensions) all federal and state income and all other tax returns, reports and declarations
required by any jurisdiction to which it is subject and (unless and only to the extent that the Company or such subsidiary has
set aside on its books provisions reasonably adequate for the payment of all unpaid and unreported taxes) has paid all taxes and
other governmental assessments and charges that are material in amount, shown or determined to be due on such returns, reports
and declarations, except those being contested in good faith and has set aside on its books provision reasonably adequate for the
payment of all taxes for periods subsequent to the periods to which such returns, reports or declarations apply. To the knowledge
of the Company, there are no unpaid taxes in any material amount claimed to be due from the Company or any subsidiary by the taxing
authority of any jurisdiction, and the officers of the Company know of no basis for any such claim.

 

		q)	Certain Transactions. Except for arm’s length transactions
pursuant to which the Company or any subsidiary makes payments in the ordinary course of business upon terms no less favorable
than it could obtain from third parties, none of the officers, directors, or employees of the Company or any subsidiary is presently
a party to any transaction with the Company or any subsidiary (other than for services as employees, officers and directors), including
any contract, agreement or other arrangement providing for the furnishing of services to or by, providing for rental of real or
personal property to or from, or otherwise requiring payments to or from any officer, director or such employee or, to the knowledge
of the Company, any corporation, partnership, trust or other entity in which any officer, director, or any such employee has a
substantial interest or is an officer, director, trustee or partner.

 

		r)	Rights of First Refusal. Except as set forth on Schedule
4c(i) or Schedule 4r, the Company is not
obligated to offer the securities offered hereunder on a right of first refusal basis or otherwise to any third parties including,
but not limited to, current or former stockholders of the Company, underwriters, brokers, agents or other third parties.

 

		s)	The Company has insurance policies of the type and in amounts
customarily carried by organizations conducting businesses or owning assets similar to those of the Company and its subsidiaries.
There is no material claim pending under any such policy as to which coverage has been questioned, denied or disputed by the underwriter
of such policy.

 

		t)	SEC Reports. The Company has filed all reports, schedules,
forms, statements and other documents required to be filed by the Company under the Securities Exchange Act of 1934, as amended,
including pursuant to Section 13(a) or 15(d) thereof, for the two years preceding the date hereof (or such shorter period as the
Company was required by law or regulation to file such material).

 

    	8

    	 

    

 

		t.	Brokers’
Fees. Except as set forth on Schedule 4t, the Company does not have any liability or obligation to pay any fees
or commissions to any broker, finder or agent with respect to the transactions contemplated by this Agreement, except for the
payment of fees to the Placement Agents as described below.

 

		u.	Disclosure Materials. The Disclosure Materials taken as a whole do not contain an untrue
statement of a material fact or omit to state a material fact necessary to make the statements therein, in the light of the circumstances
under which they were made, not misleading. The Super 8-K does not omit to state a material fact required to be stated therein.

 

		v.	Reliance. The Company acknowledges that the Subscriber is relying on the representations
and warranties made by the Company hereunder and that such representations and warranties are a material inducement to the Subscriber
purchasing the Shares. The Company further acknowledges that without such representations and warranties of the Company made hereunder,
the Subscribers would not enter into this Agreement.

 

		5.	Representations, Warranties and Agreements of the Subscriber. The Subscriber represents
and warrants to, and agrees with, the Company the following:

 

		a.	The Subscriber has the knowledge and experience in financial and business matters necessary to
evaluate the merits and risks of its prospective investment in the Company, and has carefully reviewed and understand the risks
of, and other considerations relating to, the purchase of Shares and the tax consequences of the investment, and have the ability
to bear the economic risks of the investment.

 

		b.	The Subscriber is acquiring the Shares for investment for its own account and not with the view
to, or for resale in connection with, any distribution thereof. The Subscriber understands and acknowledges that the Shares have
not been registered under the Securities Act or any state securities laws, by reason of a specific exemption from the registration
provisions of the Securities Act and applicable state securities laws, which depends upon, among other things, the bona fide nature
of the investment intent as expressed herein. The Subscriber further represents that it does not have any contract, undertaking,
agreement or arrangement with any person to sell, transfer or grant participation to any third person with respect to any of the
Shares. The Subscriber understands and acknowledges that the offering of the Shares pursuant to this Agreement will not be registered
under the Securities Act nor under the state securities laws on the ground that the sale provided for in this Agreement and the
issuance of securities hereunder is exempt from the registration requirements of the Securities Act and any applicable state securities
laws.

 

		c.	The Subscriber is an “accredited investor” as defined in Rule 501 of Regulation D as
promulgated by the SEC under the Securities Act, for the reason(s) specified on the Accredited Investor Certification
attached hereto as completed by Subscriber, and Subscriber shall submit to the Company such further assurances of such status as
may be reasonably requested by the Company. The Subscriber resides in the jurisdiction set forth on the Subscriber’s Omnibus
Signature Page affixed hereto.

 

    	9

    	 

    

 

		d.	The Subscriber (i) if a natural person, represents that he or she is the greater of (A) 21 years
of age or (B) the age of legal majority in his or her jurisdiction of residence, and has full power and authority to execute and
deliver this Agreement and all other related agreements or certificates and to carry out the provisions hereof and thereof; (ii)
if a corporation, partnership, or limited liability company or partnership, or association, joint stock company, trust, unincorporated
organization or other entity, represents that such entity was not formed for the specific purpose of acquiring the Shares, such
entity is duly organized, validly existing and in good standing under the laws of the state or jurisdiction of its organization,
the consummation of the transactions contemplated hereby is authorized by, and will not result in a violation of state law or its
charter or other organizational documents, such entity has full power and authority to execute and deliver this Agreement and all
other related agreements or certificates and to carry out the provisions hereof and thereof and to purchase and hold the Shares,
the execution and delivery of this Agreement has been duly authorized by all necessary action, this Agreement has been duly executed
and delivered on behalf of such entity and is a legal, valid and binding obligation of such entity; or (iii) if executing this
Agreement in a representative or fiduciary capacity, represents that it has full power and authority to execute and deliver this
Agreement in such capacity and on behalf of the subscribing individual, ward, partnership, trust, estate, corporation, or limited
liability company or partnership, or other entity for whom the Subscriber is executing this Agreement, and such individual, partnership,
ward, trust, estate, corporation, or limited liability company or partnership, or other entity has full right and power to perform
pursuant to this Agreement and make an investment in the Company, and represents that this Agreement constitutes a legal, valid
and binding obligation of such entity. The execution and delivery of this Agreement will not violate or be in conflict with any
order, judgment, injunction, agreement or controlling document to which the Subscriber is a party or by which it is bound.

 

		e.	The Subscriber understands that the Shares are being offered and sold to it in reliance on specific
exemptions from the registration requirements of United States federal and state securities laws and that the Company is relying
in part upon the truth and accuracy of, and such Subscriber’s compliance with, the representations, warranties, agreements,
acknowledgments and understandings of such Subscriber set forth herein in order to determine the availability of such exemptions
and the eligibility of such Subscriber to acquire such securities. The Subscriber further acknowledges and understands that the
Company is relying on the representations and warranties made by the Subscriber hereunder and that such representations and warranties
are a material inducement to the Company to sell the Shares to the Subscriber. The Subscriber further acknowledges that without
such representations and warranties of the Subscriber made hereunder, the Company would not enter into this Agreement with the
Subscriber.

 

		f.	The Subscriber understands that no public market now exists, and there may never be a public market
for, the Shares, that only a limited public market for the Company’s Common Stock exists and that there can be no assurance
that an active public market for the Common Stock will exist or continue to exist.

 

		g.	The Subscriber has received and reviewed information about the Company, including all Disclosure
Materials, and have had an opportunity to discuss the Company’s business, management and financial affairs with the Company’s
management. The Subscriber understands that such discussions, as well as any Disclosure Material provided by the Company, were
intended to describe the aspects of the Company’s business and prospects which the Company believes to be material, but were
not necessarily a thorough or exhaustive description, and except as expressly set forth in this Agreement, the Company makes no
representation or warranty with respect to the completeness of such information and makes no representation or warranty of any
kind with respect to any information provided by any entity other than the Company. Some of such information may include projections
as to the future performance of the Company, which projections may not be realized, may be based on assumptions which may not be
correct and may be subject to numerous factors beyond the Company’s control. Additionally, the Subscriber understands and
represents that it is purchasing the Shares notwithstanding the fact that the Company may disclose in the future certain material
information the Subscriber has not received, including (without limitation) financial statements of the Company and/or Akoustis
for the current or prior fiscal periods, and any subsequent period financial statements that will be filed with the SEC, that it
is not relying on any such information in connection with its purchase of the Shares and that it waives any right of action with
respect to the nondisclosure to it prior to its purchase of the Shares of any such information. Each Subscriber has sought such
accounting, legal and tax advice as it has considered necessary to make an informed investment decision with respect to its acquisition
of the Shares.

 

    	10

    	 

    

 

		h.	The Subscriber acknowledges that none of the Company or the Placement Agents is acting as a financial
advisor or fiduciary of the Subscriber (or in any similar capacity) with respect to the Transaction Documents and the transactions
contemplated hereby and thereby, and no investment advice has been given by the Company, the Placement Agents or any of their respective
representatives or agents in connection with the Transaction Documents and the transactions contemplated hereby and thereby. The
Subscriber further represents to the Company that the Subscriber’s decision to enter into the Transaction Documents has been
based solely on the independent evaluation by the Subscriber and its representatives.

 

		i.	As of the Closing, all actions on the part of Subscriber, and its officers, directors and partners,
if applicable, necessary for the authorization, execution and delivery of this Agreement and the Registration Rights Agreement
and the performance of all obligations of the Subscriber hereunder and thereunder shall have been taken, and this Agreement and
the Registration Rights Agreement, assuming due execution by the parties hereto and thereto, constitute valid and legally binding
obligations of the Subscriber, enforceable in accordance with their respective terms, subject to: (i) judicial principles limiting
the availability of specific performance, injunctive relief, and other equitable remedies and (ii) bankruptcy, insolvency, reorganization,
moratorium or other similar laws now or hereafter in effect generally relating to or affecting creditors’ rights.

 

		j.	Subscriber represents that neither it nor, to its knowledge, any person or entity controlling,
controlled by or under common control with it, nor any person having a beneficial interest in it, nor any person on whose behalf
the Subscriber is acting: (i) is a person listed in the Annex to Executive Order No. 13224 (2001) issued by the President of the
United States (Executive Order Blocking Property and Prohibiting Transactions with Persons Who Commit, Threaten to Commit, or Support
Terrorism); (ii) is named on the List of Specially Designated Nationals and Blocked Persons maintained by the U.S. Office of Foreign
Assets Control; (iii) is a non-U.S. shell bank or is providing banking services indirectly to a non-U.S. shell bank; (iv) is a
senior non-U.S. political figure or an immediate family member or close associate of such figure; or (v) is otherwise prohibited
from investing in the Company pursuant to applicable U.S. anti-money laundering, anti-terrorist and asset control laws, regulations,
rules or orders (categories (i) through (v), each a “Prohibited Subscriber”). The Subscriber agrees to
provide the Company, promptly upon request, all information that the Company reasonably deems necessary or appropriate to comply
with applicable U.S. anti-money laundering, anti-terrorist and asset control laws, regulations, rules and orders. The Subscriber
consents to the disclosure to U.S. regulators and law enforcement authorities by the Company and its affiliates and agents of such
information about the Subscriber as the Company reasonably deems necessary or appropriate to comply with applicable U.S. antimony
laundering, anti-terrorist and asset control laws, regulations, rules and orders. If the Subscriber is a financial institution
that is subject to the USA Patriot Act, the Subscriber represents that it has met all of its obligations under the USA Patriot
Act. The Subscriber acknowledges that if, following its investment in the Company, the Company reasonably believes that the Subscriber
is a Prohibited Subscriber or is otherwise engaged in suspicious activity or refuses to promptly provide information that the Company
requests, the Company has the right or may be obligated to prohibit additional investments, segregate the assets constituting the
investment in accordance with applicable regulations or immediately require the Subscriber to transfer the Shares. The Subscriber
further acknowledges that the Subscriber will have no claim against the Company or any of its affiliates or agents for any form
of damages as a result of any of the foregoing actions.

 

    	11

    	 

    

 

			If the Subscriber is affiliated with a non-U.S. banking institution (a “Foreign Bank”),
or if the Subscriber receives deposits from, makes payments on behalf of, or handles other financial transactions related to a
Foreign Bank, the Subscriber represents and warrants to the Company that: (1) the Foreign Bank has a fixed address, other than
solely an electronic address, in a country in which the Foreign Bank is authorized to conduct banking activities; (2) the Foreign
Bank maintains operating records related to its banking activities; (3) the Foreign Bank is subject to inspection by the banking
authority that licensed the Foreign Bank to conduct banking activities; and (4) the Foreign Bank does not provide banking services
to any other Foreign Bank that does not have a physical presence in any country and that is not a regulated affiliate.

 

		k.	The Subscriber or its duly authorized representative realizes that because of the inherently speculative
nature of businesses of the kind conducted and contemplated by the Company, the Company’s financial results may be expected
to fluctuate from month to month and from period to period and will, generally, involve a high degree of financial and market risk
that could result in substantial or, at times, even total losses for investors in securities of the Company.

 

		l.	The Subscriber has adequate means of providing for its current and anticipated financial needs
and contingencies, is able to bear the economic risk for an indefinite period of time and has no need for liquidity of the investment
in the Shares and could afford complete loss of such investment.

 

		m.	The Subscriber is not subscribing for Shares as a result of or subsequent to any advertisement,
article, notice or other communication, published in any newspaper, magazine or similar media or broadcast over television, radio,
or the internet, or presented at any seminar or meeting, or any solicitation of a subscription by a person not previously known
to the Subscriber in connection with investments in securities generally.

 

		n.	The Subscriber acknowledges that no U.S. federal or state agency or any other government or governmental
agency has passed upon the Shares or made any finding or determination as to the fairness, suitability or wisdom of any investments
therein.

 

		o.	The Subscriber agrees to be bound by all of the terms and conditions of the Registration Rights
Agreement and to perform all obligations thereby imposed upon it.

 

		p.	All of the information that the Subscriber has heretofore furnished or which is set forth herein
is true, correct and complete as of the date of this Agreement, and, if there should be any material change in such information
prior to the admission of the undersigned to the Company, the Subscriber will immediately furnish revised or corrected information
to the Company.

 

    	12

    	 

    

 

		q.	(For ERISA plans only) The fiduciary of the ERISA plan (the “Plan”)
represents that such fiduciary has been informed of and understands the Company’s investment objectives, policies and strategies,
and that the decision to invest “plan assets” (as such term is defined in ERISA) in the Company is consistent with
the provisions of ERISA that require diversification of plan assets and impose other fiduciary responsibilities. The Subscriber
fiduciary or Plan (a) is responsible for the decision to invest in the Company; (b) is independent of the Company or any of its
affiliates; (c) is qualified to make such investment decision; and (d) in making such decision, the Purchaser fiduciary or Plan
has not relied primarily on any advice or recommendation of the Company or any of its affiliates.

 

		6.	Transfer Restrictions. The Subscriber acknowledges and agrees as follows:

 

		a.	The Shares have not been registered for sale under the Securities Act, in reliance on the private
offering exemption in Section 4(a)(2) thereof; other than as expressly provide in the Registration Rights Agreement, the Company
does not currently intend to register the Shares under the Securities Act at any time in the future; and the undersigned will not
immediately be entitled to the benefits of Rule 144 with respect to the Shares.

 

		b.	The Subscriber understands that there are substantial restrictions on the transferability of the
Shares (collectively, the “Securities”) that the certificates representing the Securities shall bear
a restrictive legend in substantially the following form (and a stop-transfer order may be placed against transfer of such certificates
or other instruments):

 

THE
SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES
ACT”), OR ANY STATE SECURITIES LAWS, AND NEITHER SUCH SECURITIES NOR ANY INTEREST THEREIN MAY BE OFFERED, SOLD, PLEDGED,
ASSIGNED OR OTHERWISE TRANSFERRED UNLESS (1) A REGISTRATION STATEMENT WITH RESPECT THERETO IS EFFECTIVE UNDER THE SECURITIES ACT
AND ANY APPLICABLE STATE SECURITIES LAWS, OR (2) AN EXEMPTION FROM SUCH REGISTRATION EXISTS AND THE COMPANY RECEIVES AN OPINION
OF COUNSEL TO THE HOLDER OF SUCH SECURITIES, WHICH COUNSEL AND OPINION ARE SATISFACTORY TO THE COMPANY, THAT SUCH SECURITIES MAY
BE OFFERED, SOLD, PLEDGED, ASSIGNED OR TRANSFERRED IN THE MANNER CONTEMPLATED WITHOUT AN EFFECTIVE REGISTRATION STATEMENT UNDER
THE SECURITIES ACT OR APPLICABLE STATE SECURITIES LAWS. HEDGING
TRANSACTIONS INVOLVING THESE SECURITIES MAY NOT BE CONDUCTED UNLESS IN COMPLIANCE WITH THE SECURITIES ACT.

 

The legend
set forth above shall be removed and the Company shall issue a certificate without such legend to the holder of the Securities
upon which it is stamped, if (a) such Shares are sold pursuant to a registration statement under the Securities Act, or (b) such
holder delivers to the Company an opinion of counsel, reasonably acceptable to the Company, that a disposition of the Securities
is being made pursuant to an exemption from such registration and that the Securities, after such transfer, shall no longer be
“restricted securities” within the meaning of Rule 144.

 

    	13

    	 

    

 

		c.	Each Subscriber understands that prior to the Merger, the Company will be a “shell company”
as defined in Rule 12b-2 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”),
and that upon the filing of a Current Report on Form 8-K (the “Super 8-K) reporting the consummation of the Merger and the
Transactions and otherwise containing Form 10 information discussed below, the Company will cease to be a shell company. Pursuant
to Rule 144(i), securities issued by a current or former shell company (that is, the Securities) that otherwise meet the holding
period and other requirements of Rule 144 nevertheless cannot be sold in reliance on Rule 144 until one year after the Company
(a) is no longer a shell company; and (b) has filed current “Form 10 information“ (as defined in Rule 144(i)) with
the SEC reflecting that it is no longer a shell company, and provided that at the time of a proposed sale pursuant to Rule 144,
the Company is subject to the reporting requirements of Section 13 or 15(d) of the Exchange Act and has filed all reports and other
materials required to be filed by Section 13 or 15(d) of the Exchange Act, as applicable, during the preceding 12 months (or for
such shorter period that the issuer was required to file such reports and materials), other than Form 8-K reports. As a result,
the restrictive legends on certificates for the Securities cannot be removed except in connection with an actual sale meeting the
foregoing requirements or pursuant to an effective registration statement.

 

		7.	Indemnification.

 

		a.	The Subscriber agrees to indemnify and hold harmless the Company, the Placement Agents and any
other broker, agent or finder engaged by the Company for the Offering, and their respective officers, directors, employees, agents,
control persons and affiliates from and against all losses, liabilities, claims, damages, costs, fees and expenses whatsoever (including,
but not limited to, any and all expenses incurred in investigating, preparing or defending against any litigation commenced or
threatened) based upon or arising out of the Subscriber’s actual or alleged false acknowledgment, representation or warranty,
or misrepresentation or omission to state a material fact, or breach by the Subscriber of any covenant or agreement made by the
Subscriber, contained herein or in any other document delivered by the Subscriber in connection with this Agreement. The liability
of the Subscriber under this paragraph shall not exceed the total Purchase Price paid by the Subscriber hereunder.

 

		b.	The Company agrees to indemnify and hold harmless the Subscriber from and against all losses, liabilities,
claims, damages, costs, fees and expenses whatsoever (including, but not limited to, any and all expenses incurred in investigating,
preparing or defending against any litigation commenced or threatened) based upon or arising out of the Company’s actual
or alleged false acknowledgment, representation or warranty, or misrepresentation or omission to state a material fact, or breach
by the Company of any covenant or agreement made by the Company, contained herein or in any other any other Disclosure Materials.
The liability of the Company under this paragraph shall not exceed the total Purchase Price paid by the Subscriber hereunder.

 

    	14

    	 

    

 

		c.	Promptly after receipt by an indemnified party under this Section 7 of notice of the commencement
of any action, such indemnified party will, if a claim in respect thereof is to be made against the indemnifying party under this
Section 7, notify the indemnifying party in writing of the commencement thereof; but the omission so to notify the indemnifying
party will not relieve it from any liability which it may have to any indemnified party otherwise than under this Section 7. In
case any such action is brought against any indemnified party, and it notifies the indemnifying party of the commencement thereof,
the indemnifying party will be entitled to participate therein, and to the extent that it may elect by written notice delivered
to the indemnified party promptly after receiving the aforesaid notice from such indemnified party, to assume the defense thereof,
with counsel satisfactory to such indemnified party; provided, however, if the defendants in any such action include both the indemnified
party and the indemnifying party and either (i) the indemnifying party or parties and the indemnified party or parties mutually
agree or (ii) representation of both the indemnifying party or parties and the indemnified party or parties by the same counsel
is inappropriate under applicable standards of professional conduct due to actual or potential differing interests between them,
the indemnified party or parties shall have the right to select separate counsel to assume such legal defenses and to otherwise
participate in the defense of such action on behalf of such indemnified party or parties. Upon receipt of notice from the indemnifying
party to such indemnified party of its election so to assume the defense of such action and approval by the indemnified party of
counsel, the indemnifying party will not be liable to such indemnified party under this Section 7 for any legal or other expenses
subsequently incurred by such indemnified party in connection with the defense thereof unless (i) the indemnified party shall have
employed counsel in connection with the assumption of legal defenses in accordance with the proviso to the next preceding sentence
(it being understood, however, that the indemnifying party shall not be liable for the expenses of more than one separate counsel
in such circumstance), (ii) the indemnifying party shall not have employed counsel satisfactory to the indemnified party to represent
the indemnified party within a reasonable time after notice of commencement of the action or (iii) the indemnifying party has authorized
the employment of counsel for the indemnified party at the expense of the indemnifying party. No indemnifying party shall (i) without
the prior written consent of the indemnified parties (which consent shall not be unreasonably withheld), settle or compromise or
consent to the entry of any judgment with respect to any pending or threatened claim, action, suit or proceeding in respect of
which indemnification or contribution may be sought hereunder (whether or not the indemnified parties are actual or potential parties
to such claim or action) unless such settlement, compromise or consent includes an unconditional release of each indemnified party
from all liability arising out of such claim, action, suit or proceeding, or (ii) be liable for any settlement of any such action
effected without its written consent (which consent shall not be unreasonably withheld), but if settled with its written consent
or if there be a final judgment of the plaintiff in any such action, the indemnifying party agrees to indemnify and hold harmless
any indemnified party from and against any loss or liability by reason of such settlement or judgment.

 

		8.	Revocability; Binding Effect. The subscription hereunder may be revoked prior to the Closing
thereon, provided that written notice of revocation is sent and is received by the Company or a Placement Agent at least three
business days prior to the Closing on such subscription. The Subscriber hereby acknowledges and agrees that this Agreement shall
survive the death or disability of the Subscriber and shall be binding upon and inure to the benefit of the parties and their heirs,
executors, administrators, successors, legal representatives and permitted assigns. If the Subscriber is more than one person,
the obligations of the Subscriber hereunder shall be joint and several and the agreements, representations, warranties and acknowledgments
herein shall be deemed to be made by and be binding upon each such person and such person’s heirs, executors, administrators,
successors, legal representatives and permitted assigns.

 

		9.	Modification. This Agreement shall not be modified or waived except by an instrument in
writing signed by the party against whom any such modification or waiver is sought to be enforced.

 

		10.	Immaterial Modifications to the Registration Rights Agreement. The Company may, at any time
prior to the initial Closing, amend the Registration Rights Agreement if necessary to clarify any provision therein, without first
providing notice or obtaining prior consent of the Subscriber.

 

    	15

    	 

    

 

		11.	Notices. Any notice or other communication required or permitted
to be given hereunder shall be in writing and shall be mailed by certified mail, return receipt requested, or delivered against
receipt to the party to whom it is to be given (a) if to the Company, at the address set forth above, with a copy to CKR
Law LLP, 1330 Avenue of the Americas, New York, NY 10019, Attention: Barrett S. DiPaolo,
facsimile +1-212-400-6901, or (b) if to the Subscriber, at the address set forth on the Omnibus
Signature Page hereof (or, in either case, to such other address as the party shall have furnished in writing in accordance with
the provisions of this Section). Any notice or other communication given by certified mail shall be deemed given at the time of
certification thereof, except for a notice changing a party’s address which shall be deemed given at the time of receipt
thereof.

 

		12.	Assignability. This Agreement and the rights, interests and obligations hereunder are not
transferable or assignable by the Subscriber, and the transfer or assignment of the Shares shall be made only in accordance with
all applicable laws.

 

		13.	Applicable Law. This Agreement shall be governed by and construed in accordance with the
laws of the State of New York, without reference to the principles thereof relating to the conflict of laws.

 

		14.	Arbitration. The parties agree to submit all controversies to arbitration in accordance
with the provisions set forth below and understand that:

 

		a.	Arbitration shall be final and binding on the parties.

 

		b.	The parties are waiving their right to seek remedies in court, including the right to a jury trial.

 

		c.	Pre-arbitration discovery is generally more limited and different from court proceedings.

 

		d.	The arbitrator’s award is not required to include factual findings or legal reasoning and
any party’s right to appeal or to seek modification of rulings by arbitrators is strictly limited.

 

		e.	The panel of arbitrators will typically include a minority of arbitrators who were or are affiliated
with the securities industry.

 

		f.	All controversies which may arise between the parties concerning this Agreement shall be determined
by arbitration pursuant to the rules then pertaining to the Financial Industry Regulatory Authority in New York City, New York.
Judgment on any award of any such arbitration may be entered in the Supreme Court of the State of New York or in any other court
having jurisdiction of the person or persons against whom such award is rendered. Any notice of such arbitration or for the confirmation
of any award in any arbitration shall be sufficient if given in accordance with the provisions of this Agreement. The parties agree
that the determination of the arbitrators shall be binding and conclusive upon them. The prevailing party, as determined by such
arbitrators, in a legal proceeding shall be entitled to collect any costs, disbursements and reasonable attorney’s fees from
the other party. Prior to filing an arbitration, the parties hereby agree that they will attempt to resolve their differences first
by submitting the matter for resolution to a mediator, acceptable to all parties, and whose expenses will be borne equally by all
parties. The mediation will be held in the County of New York, State of New York, on an expedited basis. If the parties cannot
successfully resolve their differences through mediation, the matter will be resolved by arbitration. The arbitration shall take
place in the County of New York, State of New York, on an expedited basis.

 

    	16

    	 

    

 

		15.	Blue Sky Qualification. The purchase of Shares under this Agreement is expressly conditioned
upon the exemption from qualification of the offer and sale of the Shares from applicable federal and state securities laws. The
Company shall not be required to qualify this transaction under the securities laws of any jurisdiction and, should qualification
be necessary, the Company shall be released from any and all obligations to maintain its offer, and may rescind any sale contracted,
in the jurisdiction.

 

		16.	Use of Pronouns. All pronouns and any variations thereof used herein shall be deemed to
refer to the masculine, feminine, neuter, singular or plural as the identity of the person or persons referred to may require.

 

		17.	Confidentiality. The Subscriber acknowledges and agrees that any information or data the
Subscriber has acquired from or about the Company or may acquire in the future, not otherwise properly in the public domain, including,
without limitation, the Disclosure Materials, was received in confidence. The Subscriber agrees not to divulge, communicate or
disclose, except as may be required by law or for the performance of this Agreement, or use to the detriment of the Company or
for the benefit of any other person, or misuse in any way, any confidential information of the Company, including any scientific,
technical, trade or business secrets of the Company and any scientific, technical, trade or business materials that are treated
by the Company as confidential or proprietary, including, but not limited to, internal personnel and financial information of the
Company or its affiliates, the manner and methods of conducting the business of the Company or its affiliates and confidential
information obtained by or given to the Company about or belonging to third parties. The Subscriber understands that the Company
may rely on Subscriber’s agreement of confidentiality to comply with the exemptive provisions of Regulation FD under the
Securities Act of 1933 as set forth in Rule 100(a)(b)(2)(ii) of Regulation FD. In addition, the Subscriber acknowledges that it
is aware that the United States securities laws generally prohibit any person who is in possession of material nonpublic information
about a public company such as the Company from purchasing or selling securities of such company. The provisions of this Section
17 are in addition to and not in replacement of any other confidentiality agreement between the Company and the Subscriber.

 

		18.	Anti-Dilution. The Subscriber shall have anti-dilution protection such that if within twelve
(12) months after the final Closing of the Offering the Company shall issue Additional Shares of Common Stock (as defined below)
for a consideration per share, or with an exercise or conversion price per share, less than the Purchase Price (the “Lower
Price”), the Subscriber shall be entitled to receive from the Company (for no additional consideration) additional Shares
in an amount such that, when added to the number of Shares purchased by Subscriber under this Agreement, will equal the number
of Shares that the Subscriber’s Purchase Price for the Shares set forth on the Subscriber’s signature page hereof would
have purchased at the Lower Price.

 

    	17

    	 

    

 

“Additional
Shares of Common Stock” shall mean all shares of Common Stock issued by the Company after the first Closing of the
Offering (including without limitation any shares of Common Stock issuable upon conversion or exchange of any convertible securities
or upon exercise of any option or warrant, on an as-converted basis), other than: (i) shares of Common Stock issued or issuable
upon conversion or exchange of any convertible securities or exercise of any options or warrants outstanding as of immediately
following the Merger and the initial Closing; (ii) shares of Common Stock issued or issuable upon exercise of the Placement Agent
Warrants; (iii) shares of Common Stock issued or issuable by reason of a dividend, stock split, split-up or other distribution
on shares of Common Stock relating to any recapitalization, reclassification or reorganization of the capital stock of the Company,
or any consolidation or merger of the Company with another corporation, or the sale of all or substantially all of its assets or
other transaction effected in such a way that there is no change of control; (iv) shares of Common Stock issued in a firmly underwritten
registered public offering under the Securities Act; (v) shares of Common Stock issued or issuable pursuant to the acquisition
of another entity or business by the Company by merger, purchase of substantially all of the assets or other reorganization or
pursuant to a joint venture or technology license agreement, but not including a transaction in which the Company is issuing securities
primarily for the purpose of raising capital or to an entity whose primary business is investing in securities; (vi) shares
of Common Stock issued or issuable to officers, directors and employees of, or consultants to, the Company pursuant to stock grants,
option plans, purchase plans or other employee stock incentive programs or arrangements approved by the Board of Directors, or
upon exercise of options or warrants granted to such parties pursuant to any such plan or arrangement; (vii) any securities issued
or issuable by the Company pursuant to the Subscription Agreements; and (viii) securities issued to financial institutions, institutional
investors or lessors in connection with credit arrangements, equipment financings, lease arrangements or similar transactions,
in the aggregate not exceeding five percent (5%) of the number of shares of Common Stock outstanding at any time, and in case of
clauses (iii) through (viii) above, such issuance is approved by a majority of disinterested directors of the Company and includes
no “death spiral” provision of any kind. 

 

		19.	Miscellaneous.

 

		a.	This Agreement, together with the Registration Rights Agreement and any Confidentiality Agreement,
constitute the entire agreement between the Subscriber and the Company with respect to the Offering and supersede all prior oral
or written agreements and understandings, if any, relating to the subject matter hereof. The terms and provisions of this Agreement
may be waived, or consent for the departure therefrom granted, only by a written document executed by the party entitled to the
benefits of such terms or provisions.

 

		b.	The representations and warranties of the Company and the Subscriber made in this Agreement shall
survive the execution and delivery hereof and delivery of the Shares for a period of twelve
(12) months following the Closing Date.

 

		c.	Each of the parties hereto shall pay its own fees and expenses (including the fees of any attorneys,
accountants, appraisers or others engaged by such party) in connection with this Agreement and the transactions contemplated hereby,
whether or not the transactions contemplated hereby are consummated.

 

		d.	This Agreement may be executed in one or more original or facsimile counterparts, each of which
shall be deemed an original, but all of which shall together constitute one and the same instrument and which shall be enforceable
against the parties actually executing such counterparts. The exchange of copies of this Agreement and of signature pages by facsimile
transmission or in .pdf format shall constitute effective execution and delivery of this Agreement as to the parties and may be
used in lieu of the original Agreement for all purposes. Signatures of the parties transmitted by facsimile or in pdf format shall
be deemed to be their original signatures for all purposes.

 

		e.	Each provision of this Agreement shall be considered separable and, if for any reason any provision
or provisions hereof are determined to be invalid or contrary to applicable law, such invalidity or illegality shall not impair
the operation of or affect the remaining portions of this Agreement.

 

    	18

    	 

    

 

		f.	Paragraph titles are for descriptive purposes only and shall not control or alter the meaning of
this Agreement as set forth in the text.

 

		g.	The Subscriber understands and acknowledges that there may be multiple Closings for the Offering.

 

		h.	The Subscriber hereby agrees to furnish the Company such other information as the Company may request
prior to the Closing with respect to its subscription hereunder.

 

		20.	Omnibus Signature Page. This Agreement is intended to be read and construed in conjunction
with the Registration Rights Agreement. Accordingly, pursuant to the terms and conditions of this Agreement and the Registration
Rights Agreement, it is hereby agreed that the execution by the Subscriber of this Agreement, in the place set forth on the Omnibus
Signature Page below, shall constitute agreement to be bound by the terms and conditions hereof and the terms and conditions of
the Registration Rights Agreement, with the same effect as if each of such separate but related agreement were separately signed.

 

		21.	Public Disclosure. Neither the Subscriber nor any officer, manager, director, member, partner,
stockholder, employee, affiliate, affiliated person or entity of the Subscriber shall make or issue any press releases or otherwise
make any public statements or make any disclosures to any third person or entity with respect to the transactions contemplated
herein and will not make or issue any press releases or otherwise make any public statements of any nature whatsoever with respect
to the Company without the Company’s express prior approval. The Company has the right to withhold such approval in its sole
discretion.

 

		22.	Potential Conflicts.The Placement Agents, their
sub-agents, legal counsel to the Company and/or their respective affiliates, principals, representatives or employees may now
or hereafter own shares of the Company.

 

[Signature page follows.]

 

    	19

    	 

    

 

IN WITNESS WHEREOF, the Company has duly
executed this Subscription Agreement as of the ____ day of _________, 2015.

 

	 	AKOUSTIS TECHNOLOGIES, INC.
	 	(f/k/a Danlax, Corp.)
	 	 
	 	By:	 
	 	 	Name:	Ivan Krikun
	 	 	Title:	President

 

    	20

    	 

    

 

 

Danlax,
Corp. (intended to be renamed Akoustis Technologies, Inc.)

OMNIBUS SIGNATURE PAGE TO

SUBSCRIPTION AGREEMENT AND REGISTRATION
RIGHTS AGREEMENT

 

The undersigned, desiring to: (i) enter
into the Subscription Agreement, dated as of ____________ ___,2 2015 (the “Subscription
Agreement”), between the undersigned, Danlax, Corp., a Nevada corporation
(the “Company”), and the other parties thereto, in or substantially in the
form furnished to the undersigned, (ii) enter into the Registration Rights Agreement (the “Registration Rights Agreement”),
among the undersigned, the Company and the other parties thereto, in or substantially in the form furnished to the undersigned
and (iii) purchase the Shares of the Company’s securities as set forth in the Subscription Agreement and below, hereby agrees
to purchase such Shares from the Company and further agrees to join the Subscription Agreement and the Registration Rights Agreement
as a party thereto, with all the rights and privileges appertaining thereto, and to be bound in all respects by the terms and conditions
thereof. The undersigned specifically acknowledges having read the representations section in the Subscription Agreement entitled
“Representations and Warranties of the Subscriber” and hereby represents that the statements contained therein are
complete and accurate with respect to the undersigned as a Subscriber.

 

IN WITNESS WHEREOF, the Subscriber hereby
executes this Subscription Agreement and the Registration Rights Agreement.

 

Dated: ____________________, 2015

 

	 	X	$1.50	=	$______________
	Number of Shares	 	Purchase Price per Share	Total Purchase Price

 

	SUBSCRIBER (individual)	 	SUBSCRIBER (entity)	 
	 	 	 	 
	 	 	 	 
	Signature	 	Name of Entity	 
	 	 	 	 
	 	 	 	 
	Print Name	 	Signature	 
	 	 	 	 
	 	 	Print Name:  	 	 
	Signature (if Joint Tenants or Tenants in Common)	 	Title: 	 	 
	 	 	 	 
	Address of Principal Residence:	 	Address of Executive Offices:	 
	 	 	 	 
	 	 	 	 
	 	 	 	 
	 	 	 	 
	Social Security Number(s):	 	IRS Tax Identification Number: 	 
	 	 	 	 
	 	 	 	 
	Telephone Number:	 	Telephone Number: 	 
	 	 	 	 
	 	 	 	 
	Facsimile Number:	 	Facsimile Number: 	 
	 	 	 	 
	 	 	 	 
	E-mail Address:	 	E-mail Address: 	 
	 	 	 	 

 

 

2
Will reflect the Closing Date. Not to be completed by Subscriber.

 

    	 

    	 

    

 

Danlax,
Corp.  (intended
to be renamed Akoustis Technologies, Inc.)

ACCREDITED INVESTOR CERTIFICATION

 

For Individual Investors Only

(all Individual Investors must INITIAL
where appropriate):

 

		Initial _______	I have a net worth of at least US$1 million either individually
or through aggregating my individual holdings and those in which I have a joint, community property or other similar shared ownership
interest with my spouse. (For purposes of calculating your net worth under this paragraph, (a) your primary residence
shall not be included as an asset; (b) indebtedness secured by your primary residence, up to the estimated fair market value
of your primary residence at the time of your purchase of the securities, shall not be included as a liability (except that if
the amount of such indebtedness outstanding at the time of your purchase of the securities exceeds the amount outstanding 60 days
before such time, other than as a result of the acquisition of your primary residence, the amount of such excess shall be included
as a liability); and (c) indebtedness that is secured by your primary residence in excess of the estimated fair market value of
your primary residence at the time of your purchase of the securities shall be included as a liability.)

 

		Initial _______	I have had an annual gross income for the past two years
of at least US$200,000 (or US$300,000 jointly with my spouse) and expect my income (or joint income, as appropriate) to reach
the same level in the current year.

 

		Initial _______	I am a director or executive officer of Danlax, Corp.

 

For Non-Individual
Investors (Entities)

(all Non-Individual
Investors must INITIAL where appropriate):

 

		Initial _______	The investor certifies that it is a partnership, corporation,
limited liability company or business trust that is 100% owned by persons who meet at least one of the criteria for Individual
Investors set forth above (in which case each such person must complete the Accreditor Investor Certification for Individuals
above as well the remainder of this questionnaire) .

 

		Initial _______	The investor certifies that it is a partnership, corporation,
limited liability company or business trust that has total assets of at least US$5 million and was not formed for the purpose
of investing the Company.

 

		Initial _______	The investor certifies that it is an employee benefit plan
whose investment decision is made by a plan fiduciary (as defined in ERISA §3(21)) that is a bank, savings and loan association,
insurance company or registered investment advisor.

 

		Initial _______	The investor certifies that it is an employee benefit plan
whose total assets exceed US$5,000,000 as of the date of this Agreement.

 

		Initial _______	The undersigned certifies that it is a self-directed employee
benefit plan whose investment decisions are made solely by persons who meet at least one of the criteria for Individual Investors.

 

		Initial _______	The investor certifies that it is a U.S. bank, U.S. savings
and loan association or other similar U.S. institution acting in its individual or fiduciary capacity.

 

		Initial _______	The undersigned certifies that it is a broker-dealer registered
pursuant to §15 of the Securities Exchange Act of 1934.

 

		Initial _______	The investor certifies that it is an organization described
in §501(c)(3) of the Internal Revenue Code with total assets exceeding US$5,000,000 and not formed for the specific purpose
of investing in the Company.

 

		Initial _______	The investor certifies that it is a trust with total assets
of at least US$5,000,000, not formed for the specific purpose of investing in the Company, and whose purchase is directed by a
person with such knowledge and experience in financial and business matters that such person is capable of evaluating the merits
and risks of the prospective investment.

 

		Initial _______	The investor certifies that it is a plan established and
maintained by a state or its political subdivisions, or any agency or instrumentality thereof, for the benefit of its employees,
and which has total assets in excess of US$5,000,000.

 

		Initial _______	The investor certifies that it is an insurance company
as defined in §2(13) of the Securities Act of 1933, or a registered investment company.

 

    	 

    	 

    

 

Danlax,
Corp.  (intended to be renamed Akoustis Technologies, Inc.)

Investor Profile

(Must be completed by Investor)

 

Section A - Personal Investor Information

 

	Investor Name(s): 	 

 

	Individual executing Profile or Trustee: 	 

 

	Social Security Numbers / Federal I.D. Number: 	 

 

	Date of Birth:	 	 	Marital Status: 	 

	Joint Party Date of Birth: 	 	 	Investment Experience (Years): 	 

	Annual Income:	 	 	Liquid Net Worth: 	 

 

	Net Worth*:	 	 

 

	Tax Bracket:	_____ 15% or below	_____ 25% - 27.5%	_____ Over 27.5%

 

	Home Street Address: 	 

 

	Home City, State & Zip Code: 	 

 

	Home Phone: ______________	Home Fax: ________________	Home Email: _________________

 

	Employer: 	 

 

	Employer Street Address: 	 

 

	Employer City, State & Zip Code: 	 

 

	Bus. Phone: _______________	Bus. Fax: _______________	Bus. Email: _________________

 

	Type of Business: 	 

 

	Outside Broker/Dealer: 	 

 

Section B – Certificate Delivery
Instructions

 

____ Please deliver certificate to the Employer Address listed
in Section A.

____ Please deliver certificate to the Home Address listed in
Section A.

____ Please deliver certificate to the following address: ____________________________________________________

 

Section C – Form of Payment
– Check or Wire Transfer

 

____ Check payable to Delaware Trust
Company, as Escrow Agent for DANLAX, CORP., ACCT# 79-2363

____ Wire funds from my outside account
according to Section 2(b) of the Subscription Agreement.

____ The funds for this investment
are rolled over, tax deferred from __________ within the allowed 60 day window.

 

Please check if you are a FINRA member
or affiliate of a FINRA member firm: ____

 

	 	 	 
	Investor Signature	 	Date

 

		*	For purposes of calculating your net worth in this form, (a) your primary residence shall
not be included as an asset; (b) indebtedness secured by your primary residence, up to the estimated fair market value of your
primary residence at the time of your purchase of the securities, shall not be included as a liability (except that if the amount
of such indebtedness outstanding at the time of your purchase of the securities exceeds the amount outstanding 60 days before such
time, other than as a result of the acquisition of your primary residence, the amount of such excess shall be included as a liability);
and (c) indebtedness that is secured by your primary residence in excess of the estimated fair market value of your primary residence
at the time of your purchase of the securities shall be included as a liability. 

 

    	 

    	 

    

 

ANTI MONEY LAUNDERING REQUIREMENTS

 

The USA PATRIOT Act

 

The USA PATRIOT Act is designed to detect,
deter, and punish terrorists in the United States and abroad. The Act imposes new anti-money laundering requirements on brokerage
firms and financial institutions. Since April 24, 2002 all brokerage firms have been required to have new, comprehensive anti-money
laundering programs.

 

To help you understand these efforts, we
want to provide you with some information about money laundering and our steps to implement the USA PATRIOT Act.

 

What is money laundering?

 

Money laundering is the process of disguising
illegally obtained money so that the funds appear to come from legitimate sources or activities. Money laundering occurs in connection
with a wide variety of crimes, including illegal arms sales, drug trafficking, robbery, fraud, racketeering, and terrorism.

 

How big is the problem and why is it
important?

 

The use of the U.S. financial system by
criminals to facilitate terrorism or other crimes could well taint our financial markets. According to the U.S. State Department,
one recent estimate puts the amount of worldwide money laundering activity at $1 trillion a year.

 

What are we required to do to eliminate
money laundering?

 

Under rules required by the USA PATRIOT
Act, our anti-money laundering program must designate a special compliance officer, set up employee training, conduct independent
audits, and establish policies and procedures to detect and report suspicious transaction and ensure compliance with such laws.
As part of our required program, we may ask you to provide various identification documents or other information. Until you provide
the information or documents we need, we may not be able to effect any transactions for you.

 

    	 

    	 

    

 

ANTI-MONEY
LAUNDERING INFORMATION FORM

The following is required
in accordance with the AML provision of the USA PATRIOT ACT.

(Please
fill out and return with requested documentation.)

 

	INVESTOR
    NAME:	 	 
	 	 	 
	LEGAL
    ADDRESS: 	 	 
	 	 	 
	 	 	 
	SSN#
    or TAX ID#	 	 
	OF INVESTOR:	 	 
	 	 	 
	YEARLY
    INCOME: 	 	 
	 	 	 
	NET
    WORTH: 	 	*

 

*
For purposes of calculating your net worth in this form, (a) your primary residence shall not be included as an asset;
(b) indebtedness secured by your primary residence, up to the estimated fair market value of your primary residence at the time
of your purchase of the securities, shall not be included as a liability (except that if the amount of such indebtedness outstanding
at the time of your purchase of the securities exceeds the amount outstanding 60 days before such time, other than as a result
of the acquisition of your primary residence, the amount of such excess shall be included as a liability); and (c) indebtedness
that is secured by your primary residence in excess of the estimated fair market value of your primary residence at the time of
your purchase of the securities shall be included as a liability. 

 

INVESTMENT
OBJECTIVE(S) (FOR ALL INVESTORS):
____________________

 

ADDRESS OF BUSINESS
OR OF EMPLOYER: ____________________________

 

FOR INVESTORS WHO ARE INDIVIDUALS: AGE: ________________________

 

FOR INVESTORS WHO ARE INDIVIDUALS: OCCUPATION: _____________________________________

 

FOR INVESTORS WHO ARE ENTITIES: TYPE OF BUSINESS:
____________________________________

 

IDENTIFICATION & DOCUMENTATION
AND SOURCE OF FUNDS:

 

		1.	Please submit a copy of non-expired identification for the authorized signatory(ies) on the investment
documents, showing name, date of birth, address and signature. The address shown on the identification document MUST match the
Investor’s address shown on the Investor Signature Page.

 

	Current Driver’s License	or	Valid Passport	or	Identity Card

(Circle one or more)

 

		2.	If the Investor is a corporation, limited liability company, trust or other type of entity, please
submit the following requisite documents: (i) Articles of Incorporation, By-Laws, Certificate of Formation, Operating Agreement,
Trust or other similar documents for the type of entity; and (ii) Corporate Resolution or power of attorney or other similar document
granting authority to signatory(ies) and designating that they are permitted to make the proposed investment.

 

		3.	Please advise where the funds were derived from to make the proposed investment:

 

	Investments	Savings	Proceeds of Sale	Other ____________

(Circle one or more)

 

	Signature: 	 	 
	 	 	 
	Print Name: 	 	 
	 	 	 
	Title (if applicable):  	 	 
	 	 	 
	Date:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00245-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00245-of-00352.parquet"}]]